Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome

Obesity

Volumn 16, Issue 11, 2008, Pages 2405-2411

  De Pergola, Giovanni ^a   Giorgino, Francesco ^a   Benigno, Ritanna ^a   Guida, Pietro ^a   Giorgino, Riccardo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; INSULIN; LIOTHYRONINE; LIPID; NORADRENALIN; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; URINE;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CATECHOLAMINES; COHORT STUDIES; EPINEPHRINE; FEMALE; HUMANS; INSULIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOREPINEPHRINE; REGRESSION ANALYSIS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 55249121342     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.382     Document Type: Article

References (24)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
2. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
3. Laaksonen DE, Lakka HM, Niskanen LK et al. Metabolic syndrome and development of diabetes: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-1077.
4. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without c-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419.
5. Liao Y, Kwon S, Shaughnessy S et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004;27:978-983.
6. McLaughlin T, Abbasi F, Cheal K et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-809.
7. Cheal KL, Abbasi F, Lamendola C et al. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004;53:1195-1200.
8. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005;54:3252-3257.
9. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ 2006;332:521-525.
10. Raikkonen K, Matthews KA, Kuller LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women. Diabetes Care 2007;30:872-877.
11. Brunner EJ, Hemingway H, Walker BR et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome-nested case-control study. Circulation 2002;106:2659-2665.
12. Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004;44:847-852.
13. Grassi G, Dell'Oro R, Quarti-Trevano F et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005;48:2689-2690.
14. Landsberg L. Insulin resistance and the metabolic syndrome. Diabetologia 2005;48:1244-1246.
15. Hausberg M, Mark AL, Hoffman RP, Sinkey CA, Anderson EA. Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens 1995;13:1015-1021.
16. Grassi G, Dell'Oro R, Facchini A et al. Effect of central and peripheral boy fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004;22:2363-2369.
17. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007;92:491-496.
18. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol 2007;67:265-269.
19. Bonora E, Targher G, Alberighe M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
20. Lee ZS, Critchley JA, Tomlinson B et al. Urinary epinephrine and norepinephrine interrelations with obesity, insulin and the metabolic syndrome in Hong Kong Chinese. Metabolism 2001;50:135-143.
21. Zavaroni I, Mazza S, Dall'Aglio E et al. Prevalence of hyperinsulinemia in patients with high blood pressure. J Intern Med 1992;231:235-240.
22. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002;106:2533-2536.
23. Busetto L, Perini P, Giantin V et al. Relationship between energy expenditure and visceral fat accumulation in obese women submitted to adjustable silicone gastric banding (ASGB). Int J Obes Relat Metab Disord 1995;19:227-233.
24. Leenen R, Van der Kooy K, Deurenberg P et al. Visceral fat accumulation in obese subjects: relation to energy expenditure and response to weight loss. Am J Physiol 1992;263:E913-E919.